Article

Measuring adherence to antiretroviral treatment in resource-poor settings: the feasibility of collecting routine data for key indicators.

Center for Pharmaceutical Management, Management Sciences for Health, Arlington Virginia, USA.
BMC Health Services Research (Impact Factor: 1.66). 02/2010; 10:43. DOI: 10.1186/1472-6963-10-43
Source: PubMed

ABSTRACT An East African survey showed that among the few health facilities that measured adherence to antiretroviral therapy, practices and definitions varied widely. We evaluated the feasibility of collecting routine data to standardize adherence measurement using a draft set of indicators.
Targeting 20 facilities each in Ethiopia, Kenya, Rwanda, and Uganda, in each facility we interviewed up to 30 patients, examined 100 patient records, and interviewed staff.
In 78 facilities, we interviewed a total of 1,631 patients and reviewed 8,282 records. Difficulties in retrieving records prevented data collection in two facilities. Overall, 94.2% of patients reported perfect adherence; dispensed medicine covered 91.1% of days in a six month retrospective period; 13.7% of patients had a gap of more than 30 days in their dispensed medication; 75.8% of patients attended clinic on or before the date of their next appointment; and 87.1% of patients attended within 3 days.In each of the four countries, the facility-specific median indicators ranged from: 97%-100% for perfect self-reported adherence, 90%-95% of days covered by dispensed medicines, 2%-19% of patients with treatment gaps of 30 days or more, and 72%-91% of appointments attended on time. Individual facilities varied considerably.The percentages of days covered by dispensed medicine, patients with more than 95% of days covered, and patients with a gap of 30 days or more were all significantly correlated with the percentages of patients who attended their appointments on time, within 3 days, or within 30 days of their appointment. Self reported recent adherence in exit interviews was significantly correlated only with the percentage of patients who attended within 3 days of their appointment.
Field tests showed that data to measure adherence can be collected systematically from health facilities in resource-poor settings. The clinical validity of these indicators is assessed in a companion article. Most patients and facilities showed high levels of adherence; however, poor levels of performance in some facilities provide a target for quality improvement efforts.

0 Followers
 · 
108 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Lessons learned from treating patients with HIV infection can inform care systems for other chronic conditions. For antiretroviral treatment, attending appointments on time correlates with medication adherence; however, HIV clinics in East Africa, where attendance rates vary widely, rarely include systems to schedule appointments or to track missed appointments or patient follow-up. An introduction of low-cost, paper-based patient appointment and tracking systems led to an improvement in timely clinic attendance rates and tracking missing patients. An effective appointment system is critical to managing patients with chronic conditions and can be introduced in resource-limited settings, possibly without having to add staff.
    International Health 09/2013; 5(3):163-5. DOI:10.1093/inthealth/iht013 · 1.13 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This study evaluated medication adherence following interventions and its association with cluster of differentiation 4 (CD4) cells response among patients receiving antiretroviral therapy (ART) in Specialist Hospital Sokoto, North Western Nigeria. Longitudinal study design was used. Interventions included training of health workers on adherence counseling; pre- and post-ART adherence counseling were provided to patients. Out of 1300 patients on ART who were provided interventions, 365 patients were selected using simple random technique. The CD4-cell measurements at months 0, 6, 12, 18 and 24 were extracted from the patients’ hospital records; and announced pill counts were conducted. Chi square was used to test the association between groups of variables; and P < 0.05 indicated statistical significance. Out of 365 participants sampled, data from 297 (81.4%) participants were valid for analysis. The mean age of participants was 34.7 (95%CI, 33.6 to 35.8) years; 60.9% were females and 76.4% received Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) regimen. The mean percent adherence was 83.4% (95%CI, 80.8% to 86.0%). The mean CD4-cells count (cells/mm3) at ART initiation increased from 198.9 (95%CI, 180.7 to 217.1) to 396.5 (95%CI, 368.3 to 424.7) at 6 months, 428.0 (95%CI, 400.4 to 455.6) at 12 months, 427.2 (95%CI, 405.6 to 448.8) at 18 months, and 501.4 (95%CI, 469.5 to 533.3) at 24 months. This increase was statistically significant (P< 0.05). Participants’ employment and educational status, age, sex and type of ART regimens received had no significant association with medication adherence (P > 0.05). This study reported a mean adherence level that is below the required >95% necessary to achieve the goals of ART. The increase in CD4 cells count over the observation period was statistically significant at the estimated adherence level. Better immunologic outcomes may be achieved with higher adherence level.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective: To assess the effects of facility-based interventions using existing resources to improve overall patient attendance and adherence to antiretroviral therapy (ART) at ART-providing facilities in Uganda. Methods: This was an interventional study which tracked attendance and treatment adherence of two distinct cohorts: experienced patients who had been on treatment for at least 12 months prior to the intervention and patients newly initiated on ART before or during the intervention. The interventions included instituting appointment system, fast-tracking, and giving longer prescriptions to experienced stable patients. Mixed-effects models were used to examine intervention effects on the experienced patients, while Cox proportional hazards models were used to determine the intervention effects on time until newly treated patients experienced gaps in medication availability. Results: In all, 1481 patients' files were selected for follow-up from six facilities - 720 into the experienced cohort, and 761 into the newly treated cohort. Among patients in the experienced cohort, the interventions were associated with a significant reduction from 24.4 to 20.3% of missed appointments (adjusted odds ratio (AOR): 0.67; 95% confidence interval (CI): 0.59-0.77); a significant decrease from 20.2 to 18.4% in the medication gaps of three or more days (AOR: 0.69; 95% CI: 0.60-0.79); and a significant increase from 4.3 to 9.3% in the proportion of patients receiving more than 30 days of dispensed medication (AOR: 2.35; 95% CI: 1.91-2.89). Among newly treated patients, the interventions were associated with significant reductions of 44% (adjusted hazard rate (AHR): 0.56, 95% CI: 0.42-0.74) and 38% (AHR: 0.62; 95% CI: 0.45-0.85) in the hazards of experiencing a medication gap of 7 and 14 days or more, respectively. Conclusions: Patients' adherence was improved with low-cost and easily implemented interventions using existing health facilities' resources. We recommend that such interventions be considered for scale-up at national levels as measures to improve clinic attendance and ART adherence among patients in Uganda and other low-resource settings in sub-Saharan Africa.
    Global Health Action 06/2014; 7:24198. DOI:10.3402/gha.v7.24198 · 1.65 Impact Factor

Full-text (4 Sources)

Download
22 Downloads
Available from
May 30, 2014